Article Cited by others


Clinical and economic burden of adverse drug reactions

Sultana Janet, Cutroneo Paola, Trifirò Gianluca

Year : 2013| Volume: 4| Issue : 5 | Page no: 73-77

   This article has been cited by
1 Pharmacovigilance in Calabria (Italy): Local experiences resonate international relevance
Russo, E., De Sarro, G.
Journal of Pharmacology and Pharmacotherapeutics. 4; 1(S1): S3
[Pubmed]  [Google Scholar]
2 Learning predictive models of drug side-effect relationships from distributed representations of literature-derived semantic predications
Justin Mower,Devika Subramanian,Trevor Cohen
Journal of the American Medical Informatics Association. 2018;
[Pubmed]  [Google Scholar] [DOI]
3 Adverse Drug Reactions Reported by Healthcare Professionals: Reaction Characteristics and Time to Reporting
Ar Kar Aung,Mei Jie Tang,Nikki Rae Adler,Sara Lee de Menezes,Michelle Sue Yen Goh,Hui Wen Tee,Jason Anthony Trubiano,Robert Puy,Celia Mary Zubrinich,Linda Velta Graudins
The Journal of Clinical Pharmacology. 2018;
[Pubmed]  [Google Scholar] [DOI]
4 The economic burden of preventable adverse drug reactions: a systematic review of observational studies
D Formica,J Sultana,PM Cutroneo,S Lucchesi,R Angelica,S Crisafulli,Y Ingrasciotta,F Salvo,E Spina,G Trifirò
Expert Opinion on Drug Safety. 2018; 17(7): 681
[Pubmed]  [Google Scholar] [DOI]
5 OpenPVSignal: Advancing Information Search, Sharing and Reuse on Pharmacovigilance Signals via FAIR Principles and Semantic Web Technologies
Pantelis Natsiavas,Richard D. Boyce,Marie-Christine Jaulent,Vassilis Koutkias
Frontiers in Pharmacology. 2018; 9
[Pubmed]  [Google Scholar] [DOI]
6 Healthcare professionals’ knowledge, attitude and practice towards adverse drug reaction (ADR) reporting at the health center level in Ethiopia
Mohammed Assen Seid,Asmamaw Emagn Kasahun,Bamlak Markos Mante,Saron Naji Gebremariam
International Journal of Clinical Pharmacy. 2018;
[Pubmed]  [Google Scholar] [DOI]
7 Biomarkers of adverse drug reactions
Daniel F Carr,Munir Pirmohamed
Experimental Biology and Medicine. 2018; 243(3): 291
[Pubmed]  [Google Scholar] [DOI]
8 An Interdigitated Electrode Biosensor Platform for Rapid HLA-B*15:02 Genotyping for Prevention of Drug Hypersensitivity
Gita V. Soraya,Jianxiong Chan,Thanh C. Nguyen,Duc H. Huynh,Chathurika D. Abeyrathne,Gursharan Chana,Marian Todaro,Efstratios Skafidas,Patrick Kwan
Biosensors and Bioelectronics. 2018;
[Pubmed]  [Google Scholar] [DOI]
9 Predicting serious rare adverse reactions of novel chemicals
Aleksandar Poleksic,Lei Xie
Bioinformatics. 2018;
[Pubmed]  [Google Scholar] [DOI]
10 Impact of nanomedicine on hepatic cytochrome P450 3A4 activity: things to consider during pre-clinical and clinical studies
Kristina Jonsson-Schmunk,Stephen C. Schafer,Maria A. Croyle
Journal of Pharmaceutical Investigation. 2018; 48(1): 113
[Pubmed]  [Google Scholar] [DOI]
11 Pharmacomicrobiomics: a novel route towards personalized medicine?
Marwah Doestzada,Arnau Vich Vila,Alexandra Zhernakova,Debby P. Y. Koonen,Rinse K. Weersma,Daan J. Touw,Folkert Kuipers,Cisca Wijmenga,Jingyuan Fu
Protein & Cell. 2018;
[Pubmed]  [Google Scholar] [DOI]
12 Adverse Drug Reactions in Hospitalized Patients: Results of the FORWARD (Facilitation of Reporting in Hospital Ward) Study
Claudia Giardina,Paola M. Cutroneo,Eleonora Mocciaro,Giuseppina T. Russo,Giuseppe Mandraffino,Giorgio Basile,Franco Rapisarda,Rosarita Ferrara,Edoardo Spina,Vincenzo Arcoraci
Frontiers in Pharmacology. 2018; 9
[Pubmed]  [Google Scholar] [DOI]
13 Urgent need to modernize pharmacovigilance education in healthcare curricula: review of the literature
Michael Reumerman,J. Tichelaar,B. Piersma,M. C. Richir,M. A. van Agtmael
European Journal of Clinical Pharmacology. 2018;
[Pubmed]  [Google Scholar] [DOI]
14 Detecting Adverse Drug Reactions on Twitter with Convolutional Neural Networks and Word Embedding Features
Aaron J. Masino,Daniel Forsyth,Alexander G. Fiks
Journal of Healthcare Informatics Research. 2018;
[Pubmed]  [Google Scholar] [DOI]
15 Pharmacovigilance in developing countries (part I): importance and challenges
Shaimaa Elshafie,Iman Zaghloul,Anne Marie Roberti
International Journal of Clinical Pharmacy. 2017;
[Pubmed]  [Google Scholar] [DOI]
16 Identifying the common genetic networks of ADR (adverse drug reaction) clusters and developing an ADR classification model
Youhyeon Hwang,Min Oh,Giup Jang,Taekeon Lee,Chihyun Park,Jaegyoon Ahn,Youngmi Yoon
Mol. BioSyst.. 2017;
[Pubmed]  [Google Scholar] [DOI]
17 Pharmacogenomics of GPCR Drug Targets
Alexander S. Hauser,Sreenivas Chavali,Ikuo Masuho,Leonie J. Jahn,Kirill A. Martemyanov,David E. Gloriam,M. Madan Babu
Cell. 2017;
[Pubmed]  [Google Scholar] [DOI]
18 Pharmacokinetics and Safety of Omadacycline in Subjects with Impaired Renal Function
Jolene K. Berg,Evan Tzanis,Lynne Garrity-Ryan,Stephen Bai,Surya Chitra,Amy Manley,Stephen Villano
Antimicrobial Agents and Chemotherapy. 2017; 62(2): e02057-17
[Pubmed]  [Google Scholar] [DOI]
19 Machine learning workflow to enhance predictions of Adverse Drug Reactions (ADRs) through drug-gene interactions: application to drugs for cutaneous diseases
Kalpana Raja,Matthew Patrick,James T. Elder,Lam C. Tsoi
Scientific Reports. 2017; 7(1)
[Pubmed]  [Google Scholar] [DOI]
20 Prescribing indicators in primary health care in Belo Horizonte, Brazil: associated factors
Marina Guimarães Lima,Kátia Reis Dutra,Ursula Carolina Morais Martins
International Journal of Clinical Pharmacy. 2017;
[Pubmed]  [Google Scholar] [DOI]
21 Use of a trigger tool to detect adverse drug reactions in an emergency department
Silvana Maria de Almeida,Aruana Romualdo,Andressa de Abreu Ferraresi,Giovana Roberta Zelezoglo,Alexandre R. Marra,Michael B. Edmond
BMC Pharmacology and Toxicology. 2017; 18(1)
[Pubmed]  [Google Scholar] [DOI]
22 Models of Models: A Translational Route for Cancer Treatment and Drug Development
Lesley A. Ogilvie,Aleksandra Kovachev,Christoph Wierling,Bodo M. H. Lange,Hans Lehrach
Frontiers in Oncology. 2017; 7
[Pubmed]  [Google Scholar] [DOI]
23 Is inpatient bed number associated with the length of stay? A retrospective, single centre analysis
Daniel Cromb,Ronny Cheung,Paul Blaker
British Journal of Healthcare Management. 2017; 23(9): 426
[Pubmed]  [Google Scholar] [DOI]
24 A dataset quantifying polypharmacy in the United States
Katie J. Quinn,Nigam H. Shah
Scientific Data. 2017; 4: 170167
[Pubmed]  [Google Scholar] [DOI]
25 Intensive Care in a Patient with Toxic Epidermal Necrolysis
J. Wallenborn,M. Fischer
Case Reports in Critical Care. 2017; 2017: 1
[Pubmed]  [Google Scholar] [DOI]
26 Adverse Health Events Related to Self-Medication Practices Among Elderly: A Systematic Review
Médéa Locquet,Germain Honvo,Véronique Rabenda,Thierry Van Hees,Jean Petermans,Jean-Yves Reginster,Olivier Bruyère
Drugs & Aging. 2017;
[Pubmed]  [Google Scholar] [DOI]
27 Deep learning for pharmacovigilance: recurrent neural network architectures for labeling adverse drug reactions in Twitter posts
Anne Cocos,Alexander G Fiks,Aaron J Masino
Journal of the American Medical Informatics Association. 2017;
[Pubmed]  [Google Scholar] [DOI]
28 ß-Lactam Therapy for Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Comparative Review of Cefazolin versus Antistaphylococcal Penicillins
Julius Li,Kelly L. Echevarria,Kristi A. Traugott
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2017;
[Pubmed]  [Google Scholar] [DOI]
29 FarmaREL: An Italian pharmacovigilance project to monitor and evaluate adverse drug reactions in haematologic patients
Nicola S. Fracchiolla,Silvia Artuso,Agostino Cortelezzi,Anna M. Pelizzari,Paola Tozzi,Maurizio Bonfichi,Federica Bocchio,Livio Gargantini,Elisa De Rosa,Giuseppe D. Vighi,Lucia Prestini,Simona Sammassimo,Niccolò Frungillo,Maria C. Pasquini,Alessandra Ragazzi,Daniele Boghi,Alessia Pastore,Eraldo Lanzi,Giuseppe Gritti,Giulia Quaresmini,Simone Voltolini,Roberta Gaiardoni,Consuelo Corti,Maria C. Vilardo,Maria L. La Targia,Giacomo Berini,Massimo Magagnoli,Claudia Bacci,Dario Consonni,Alma L. Rivolta,Giuliana Muti
Hematological Oncology. 2017;
[Pubmed]  [Google Scholar] [DOI]
30 The key role of clinical and community health nurses in pharmacovigilance
Caterina Bigi,Guido Bocci
European Journal of Clinical Pharmacology. 2017;
[Pubmed]  [Google Scholar] [DOI]
31 Facilitating prediction of adverse drug reactions by using knowledge graphs and multi-label learning models
Emir Muñoz,Vít Novácek,Pierre-Yves Vandenbussche
Briefings in Bioinformatics. 2017;
[Pubmed]  [Google Scholar] [DOI]
32 Testing an explanatory model of nurses’ intention to report adverse drug reactions in hospital settings
Alessia De Angelis,Luca Pancani,Patrizia Steca,Sofia Colaceci,Angela Giusti,Laura Tibaldi,Rosaria Alvaro,Davide Ausili,Ercole Vellone
Journal of Nursing Management. 2017;
[Pubmed]  [Google Scholar] [DOI]
33 Feasibility and Educational Value of a Student-Run Pharmacovigilance Programme: A Prospective Cohort Study
Tim Schutte,Jelle Tichelaar,Michael O. Reumerman,Rike van Eekeren,Leàn Rolfes,Eugène P. van Puijenbroek,Milan C. Richir,Michiel A. van Agtmael
Drug Safety. 2017;
[Pubmed]  [Google Scholar] [DOI]
34 Adverse drug reactions reporting in Calabria (Southern Italy) in the four-year period 2011-2014: impact of a regional pharmacovigilance project in light of the new European Legislation
Christian Leporini,Giuseppina Marrazzo,Laura Mumoli,Stefania Esposito,Luca Gallelli,Giovanna Mangano,Giacomino Brancati,Emanuela Adele De Francesco,Emilio Russo,Giovambattista De Sarro
Expert Opinion on Drug Safety. 2017; : 1
[Pubmed]  [Google Scholar] [DOI]
35 Adverse drug reactions in high-risk pregnant women: A prospective study
Alfredo Dias de Oliveira-Filho,Antonio Emanuel Soares Vieira,Roberta Cruz da Silva,Sabrina Joany Felizardo Neves,Thiago Antonio Barros Gama,Ryane Vieira Lima,Wlisses Ramon Oliveira,Júlia Maria de Gonçalves Dias
Saudi Pharmaceutical Journal. 2017;
[Pubmed]  [Google Scholar] [DOI]
36 Using deep learning to improve medication safety: the untapped potential of social media
Jiaheng Xie,Daniel Dajun Zeng,Zachary A. Marcum
Therapeutic Advances in Drug Safety. 2017; 8(12): 375
[Pubmed]  [Google Scholar] [DOI]
37 Concurrent Use of Prescription Drugs and Herbal Medicinal Products in Older Adults: A Systematic Review
Taofikat B. Agbabiaka,Barbara Wider,Leala K. Watson,Claire Goodman
Drugs & Aging. 2017;
[Pubmed]  [Google Scholar] [DOI]
38 Concurrent use of prescription drugs and herbal medicinal products in older adults: a systematic review protocol
Taofikat Agbabiaka,Barbara Wider,Leala Kay Watson,Claire Goodman
Systematic Reviews. 2016; 5(1)
[Pubmed]  [Google Scholar] [DOI]
39 Role of pharmacogenetics in public health and clinical health care: a SWOT analysis
Ritika Kapoor,Wei Chuen Tan-Koi,Yik-Ying Teo
European Journal of Human Genetics. 2016;
[Pubmed]  [Google Scholar] [DOI]
40 Pharmacovigilance Skills, Knowledge and Attitudes in our Future Doctors - A Nationwide Study in the Netherlands
Tim Schutte,Jelle Tichelaar,Michael O. Reumerman,Rike van Eekeren,Robert Rissmann,Cornelis Kramers,Milan C. Richir,Eugène P. van Puijenbroek,Michiel A. van Agtmael
Basic & Clinical Pharmacology & Toxicology. 2016;
[Pubmed]  [Google Scholar] [DOI]
41 Generalized enrichment analysis improves the detection of adverse drug events from the biomedical literature
Rainer Winnenburg,Nigam H. Shah
BMC Bioinformatics. 2016; 17(1)
[Pubmed]  [Google Scholar] [DOI]
42 Risk management of QTc-prolongation in patients receiving haloperidol: an epidemiological study in a University hospital in Belgium
Eline Vandael,Bert Vandenberk,Joris Vandenberghe,Isabel Spriet,Rik Willems,Veerle Foulon
International Journal of Clinical Pharmacy. 2016;
[Pubmed]  [Google Scholar] [DOI]
43 Adverse Drug Reaction Reporting Pattern in Turkey: Analysis of the National Database in the Context of the First Pharmacovigilance Legislation
Gulnihal Ozcan,Emel Aykac,Yelda Kasap,Nergiz T. Nemutlu,Ebru Sen,N. Demet Aydinkarahaliloglu
Drugs - Real World Outcomes. 2016;
[Pubmed]  [Google Scholar] [DOI]
44 Regulatory development of geriatric medicines: To GIP or not to GIP?
Bart De Spiegeleer,Evelien Wynendaele,Nathalie Bracke,Lieselotte Veryser,Lien Taevernier,Agnes Degroote,Sofie Stalmans
Ageing Research Reviews. 2016; 27: 23
[Pubmed]  [Google Scholar] [DOI]
45 Adverse drug reactions reporting: a questionnaire-based study on Egyptian pharmacists’ attitudes following an awareness workshop
Nehal A Alraie,Amr A Saad,Nirmeen A Sabry,Samar F Farid
Journal of Evaluation in Clinical Practice. 2016; : n/a
[Pubmed]  [Google Scholar] [DOI]
46 Purification and biochemical characterization of glucose 6-phosphate dehydrogenase, 6-phosphogluconate dehydrogenase and glutathione reductase from rat lung and inhibition effects of some antibiotics
Sevki Adem,Mehmet Ciftci
Journal of Enzyme Inhibition and Medicinal Chemistry. 2016; : 1
[Pubmed]  [Google Scholar] [DOI]
47 UK Pharmacogenetics and Stratified Medicine Network
Christine J McNamee
Personalized Medicine. 2016; 13(2): 107
[Pubmed]  [Google Scholar] [DOI]
48 Prevalence and characteristics of adverse drug reactions at admission to hospital: a prospective observational study
Sze Ling Chan,Xiaohui Ang,Levana L. Sani,Hong Yen Ng,Michael D. Winther,Jian Jun Liu,Liam R. Brunham,Alexandre Chan
British Journal of Clinical Pharmacology. 2016; 82(6): 1636
[Pubmed]  [Google Scholar] [DOI]
49 Introducing the Microbiome into Precision Medicine
Thomas M. Kuntz,Jack A. Gilbert
Trends in Pharmacological Sciences. 2016;
[Pubmed]  [Google Scholar] [DOI]
50 Adverse drug reactions experience in a teaching hospital in Jordan
Mohammed Alsbou,Sameh Alzubiedi,Hamed Alzobi,Nawal Abu Samhadanah,Yousef Alsaraireh,Omar Alrawashdeh,Amin Aqel,Khalil Al-Salem
International Journal of Clinical Pharmacy. 2015; 37(6): 1188
[Pubmed]  [Google Scholar] [DOI]
51 Pharmacovigilance in resource-limited countries
Sten Olsson,Shanthi N Pal,Alex Dodoo
Expert Review of Clinical Pharmacology. 2015; 8(4): 449
[Pubmed]  [Google Scholar] [DOI]
52 Anticoagulant-related hospital admissions: serious adverse reactions identified through hospital databases
Charles Heng,Marie Christine Rybarczyk-Vigouret,Bruno Michel
Pharmacoepidemiology and Drug Safety. 2015; 24(2): 144
[Pubmed]  [Google Scholar] [DOI]
53 Telemedicine and the Patient with Sepsis
Omar Badawi,Erkan Hassan
Critical Care Clinics. 2015; 31(2): 291
[Pubmed]  [Google Scholar] [DOI]
54 Factors that condition the spontaneous reporting of adverse drug reactions among nurses: an integrative review
Alessia De Angelis,Sofia Colaceci,Angela Giusti,Ercole Vellone,Rosaria Alvaro
Journal of Nursing Management. 2015; : n/a
[Pubmed]  [Google Scholar] [DOI]
55 Pharmacometabonomics in humans: a new tool for personalized medicine
Jeremy R Everett
Pharmacogenomics. 2015; 16(7): 737
[Pubmed]  [Google Scholar] [DOI]
56 Nurse-Led Medicinesæ Monitoring for Patients with Dementia in Care Homes: A Pragmatic Cohort Stepped Wedge Cluster Randomised Trial
Susan Jordan,Marie Ellenor Gabe-Walters,Alan Watkins,Ioan Humphreys,Louise Newson,Sherrill Snelgrove,Michael S Dennis,Matthias Briel
PLOS ONE. 2015; 10(10): e0140203
[Pubmed]  [Google Scholar] [DOI]
57 The emergence of precision therapeutics
Jim Slater,Laura Shields,Ray J. Racette,Donald Juzwishin,Max Coppes
Healthcare Management Forum. 2015; 28(6_suppl): S33
[Pubmed]  [Google Scholar] [DOI]
58 L’émergence de la thérapeutique de précision
Jim Slater,Laura Shields,Ray J. Racette,Donald Juzwishin,Max Coppes
Healthcare Management Forum. 2015; 28(6_suppl): S40
[Pubmed]  [Google Scholar] [DOI]
59 Drug disposition alterations in liver disease: extrahepatic effects in cholestasis and nonalcoholic steatohepatitis
Mark J Canet,Nathan J Cherrington
Expert Opinion on Drug Metabolism & Toxicology. 2014; 10(9): 1209
[Pubmed]  [Google Scholar] [DOI]
60 Medicinesæ management: a public health problem on nursingæs agenda
Sue Jordan,Una Kyriacos
Journal of Nursing Management. 2014; 22(3): 271
[Pubmed]  [Google Scholar] [DOI]
61 Adherence to therapy and adverse drug reactions: is there a link?
Christian Leporini,Giovambattista De Sarro,Emilio Russo
Expert Opinion on Drug Safety. 2014; 13(S1): 41
[Pubmed]  [Google Scholar] [DOI]
62 The emerging era of pharmacogenomics: current successes, future potential, and challenges
J.W. Lee,F. Aminkeng,A.P. Bhavsar,K. Shaw,B.C. Carleton,M.R. Hayden,C.J.D. Ross
Clinical Genetics. 2014; : n/a
[Pubmed]  [Google Scholar] [DOI]


Read this article